These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7806594)

  • 1. Human breast and colon cancers exhibit alterations of DNA methylation patterns at several DNA segments on chromosomes 11p and 17p.
    Ribieras S; Song-Wang XG; Martin V; Lointier P; Frappart L; Dante R
    J Cell Biochem; 1994 Sep; 56(1):86-96. PubMed ID: 7806594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered chromosomal methylation patterns accompany oncogene-induced transformation of human bronchial epithelial cells.
    Vertino PM; Spillare EA; Harris CC; Baylin SB
    Cancer Res; 1993 Apr; 53(7):1684-9. PubMed ID: 8453642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of DNA methylation of chromosomal hot spots associated with breast cancer.
    Kass DH; Shen M; Appel NB; Anderson DE; Saunders GF
    Anticancer Res; 1993; 13(5A):1245-51. PubMed ID: 8239493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancer.
    Fujii H; Biel MA; Zhou W; Weitzman SA; Baylin SB; Gabrielson E
    Oncogene; 1998 Apr; 16(16):2159-64. PubMed ID: 9572497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant hypermethylation at the bcl-2 locus at 18q21 in human lung cancers.
    Nagatake M; Osada H; Kondo M; Uchida K; Nishio M; Shimokata K; Takahashi T; Takahashi T
    Cancer Res; 1996 Apr; 56(8):1886-91. PubMed ID: 8620509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.
    Costello JF; Frühwald MC; Smiraglia DJ; Rush LJ; Robertson GP; Gao X; Wright FA; Feramisco JD; Peltomäki P; Lang JC; Schuller DE; Yu L; Bloomfield CD; Caligiuri MA; Yates A; Nishikawa R; Su Huang H; Petrelli NJ; Zhang X; O'Dorisio MS; Held WA; Cavenee WK; Plass C
    Nat Genet; 2000 Feb; 24(2):132-8. PubMed ID: 10655057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B.
    Herman JG; Jen J; Merlo A; Baylin SB
    Cancer Res; 1996 Feb; 56(4):722-7. PubMed ID: 8631003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal methylation of the calcitonin gene in human colonic neoplasms.
    Silverman AL; Park JG; Hamilton SR; Gazdar AF; Luk GD; Baylin SB
    Cancer Res; 1989 Jul; 49(13):3468-73. PubMed ID: 2731168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity in sporadic human breast carcinoma: a common region between 11q22 and 11q23.3.
    Hampton GM; Mannermaa A; Winqvist R; Alavaikko M; Blanco G; Taskinen PJ; Kiviniemi H; Newsham I; Cavenee WK; Evans GA
    Cancer Res; 1994 Sep; 54(17):4586-9. PubMed ID: 8062246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of DNA methylation markers for human breast carcinomas using the methylation-sensitive restriction fingerprinting technique.
    Huang TH; Laux DE; Hamlin BC; Tran P; Tran H; Lubahn DB
    Cancer Res; 1997 Mar; 57(6):1030-4. PubMed ID: 9067264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
    Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
    Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypermethylation in histologically distinct classes of breast cancer.
    Bae YK; Brown A; Garrett E; Bornman D; Fackler MJ; Sukumar S; Herman JG; Gabrielson E
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):5998-6005. PubMed ID: 15447983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic loss on a chromosome 17 in ductal carcinoma in situ of the breast.
    Radford DM; Fair K; Thompson AM; Ritter JH; Holt M; Steinbrueck T; Wallace M; Wells SA; Donis-Keller HR
    Cancer Res; 1993 Jul; 53(13):2947-9. PubMed ID: 8391383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas.
    Baylin SB; Höppener JW; de Bustros A; Steenbergh PH; Lips CJ; Nelkin BD
    Cancer Res; 1986 Jun; 46(6):2917-22. PubMed ID: 3009002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of DNA hypomethylation with expression of carcinoembryonic antigen in human colon carcinoma cells.
    Tran R; Kashmiri SV; Kantor J; Greiner JW; Pestka S; Shively JE; Schlom J
    Cancer Res; 1988 Oct; 48(20):5674-9. PubMed ID: 3167826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-specific methylation patterns of erbB2 (HER2/neu) sequences in gastro-intestinal cancer.
    Holzmann K; Welter C; Klein V; Pistorius G; Seitz G; Blin N
    Anticancer Res; 1992; 12(3):1013-8. PubMed ID: 1352439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer.
    Zhuang Z; Merino MJ; Chuaqui R; Liotta LA; Emmert-Buck MR
    Cancer Res; 1995 Feb; 55(3):467-71. PubMed ID: 7834608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups.
    Courjal F; Cuny M; Simony-Lafontaine J; Louason G; Speiser P; Zeillinger R; Rodriguez C; Theillet C
    Cancer Res; 1997 Oct; 57(19):4360-7. PubMed ID: 9331099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
    Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV
    Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation-associated silencing of heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers.
    Miyamoto K; Asada K; Fukutomi T; Okochi E; Yagi Y; Hasegawa T; Asahara T; Sugimura T; Ushijima T
    Oncogene; 2003 Jan; 22(2):274-80. PubMed ID: 12527896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.